SEC Tracker
Get the app

Adial Pharmaceuticals AZR

Adial Pharmaceuticals: Securities offering (amended)

Securities offering (amended)

Form
S-3/A
Filed
Importance
Routine
  1. 25,148,970 shares of common stock proposed for resale
  2. 437,421 shares from Azora merger
  3. 12,930,601 shares from preferred stock conversion
  4. 9,749,345 shares from PIPE pre-funded warrants

Written from the S-3/A on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Adial Pharmaceuticals files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. AIM ImmunoTech AIM public float $6M, Jun 30, 2025
  2. Vyome Holdings HIND public float $6M, Jun 30, 2025
  3. Biomerica BMRA public float $7M, Nov 28, 2025
  4. Protagenic Therapeutics, Inc.\new PTIX public float $7M, Sep 30, 2025
  5. PharmaCyte Biotech PMCB public float $6M, Oct 31, 2025